Can a prior tuberculosis infection cause a positive QuantiFERON‑Gold (interferon‑γ release assay) result?

Yes, a past TB infection can cause a positive QuantiFERON-Gold test

A prior tuberculosis infection—whether latent (LTBI) or previously treated active TB—will typically cause a positive QuantiFERON-Gold result, as the test detects immune memory to Mycobacterium tuberculosis antigens that persists after infection. However, the sensitivity is imperfect, particularly in those with remote or adequately treated disease.

How QuantiFERON-Gold Works

The QuantiFERON-Gold assay measures interferon-γ release from T-cells in response to M. tuberculosis-specific antigens (ESAT-6 and CFP-10). These antigens are:

• Present in all M. tuberculosis strains
• Absent from BCG vaccine strains and most nontuberculous mycobacteria 1
• Recognized by immune memory cells that develop after TB infection

This means the test detects immune sensitization to TB, not active disease itself 2, 1.

Key Clinical Principle: Cannot Distinguish Active from Latent TB

Neither QuantiFERON-Gold nor TST can distinguish between latent TB infection and active tuberculosis disease 2, 1. The test simply indicates that the immune system has been exposed to and "remembers" M. tuberculosis antigens—whether from:

• Current active TB
• Remote treated TB
• Latent infection
• Recent exposure

This is why active TB must always be excluded clinically before diagnosing LTBI, using history, physical exam, chest radiograph, and when indicated, sputum testing 1.

Sensitivity Limitations in Past TB

The test is not 100% sensitive for detecting prior TB infection:

• In one study of HIV patients with previous culture-proven TB, only 29% (4 of 14) had positive IGRAs 3
• In Japanese RA patients with past TB history, only 13.6% were positive at the standard 0.35 IU/mL cutoff, increasing to 27.3% at a lower 0.1 IU/mL threshold 4
• Sensitivity ranges from 65-100% in immunocompromised populations 2

Factors reducing sensitivity include:

• Remote infection (years since exposure)
• Adequately treated prior TB
• Immunosuppression (HIV, TNF-α inhibitors, corticosteroids)
• Nutritional status and host health 2, 4

Clinical Interpretation Algorithm

When evaluating a QuantiFERON-Gold result in someone with possible past TB:

1. Positive result (≥0.35 IU/mL): Indicates M. tuberculosis infection at some point—could be remote treated TB, LTBI, or active disease

   • Must exclude active TB with symptoms review, chest X-ray, and sputum if indicated 1
   • Consider epidemiologic history and radiographic findings (e.g., fibrotic changes suggesting old TB) 1, 5

2. Negative result: Does NOT exclude prior TB infection, especially if:

   • Infection was remote or adequately treated
   • Patient is immunocompromised
   • Patient has documented prior active TB 3, 6

3. Indeterminate result: May indicate technical issues, very high background inflammation, or rarely anti-interferon-γ autoantibodies 1, 7

   • Repeat with new blood sample 1

Important Caveats

• A negative QuantiFERON-Gold cannot rule out active TB when clinical suspicion is high based on symptoms, imaging, or epidemiology 6
• Results near the 0.35 IU/mL cutoff are less reliable than those far above or below 2
• In persons with documented prior TB and high reactivation risk (e.g., starting TNF inhibitors), consider treatment regardless of test result if radiographic evidence of old TB exists 1, 4
• Serial testing may show conversions or reversions due to test variability (FDA accepts 11% variance) or true immunologic changes 2, 8

Bottom Line for Clinical Practice

Interpret QuantiFERON-Gold results in context of the complete clinical picture—not in isolation 1. A positive test in someone with known prior TB simply confirms persistent immune memory, while a negative test does not exclude past infection, particularly if remote or treated. The critical clinical decision is whether active TB is present now, which requires clinical evaluation beyond the blood test alone.